Back to search

Massachusetts Institute of Technology

Pharmaceutical crystallization design using micromixers, multiphase flow, and controlled dynamic operations

Abstract

dc:description.abstract

Crystallization is a key unit operation in the pharmaceutical industry. Control of crystallization processes can be challenging when undesirable phenomena such as particle attrition and breakage occur. This thesis describes the controlled crystallization of pharmaceuticals and amino acids for more efficient manufacturing processes and better efficacy of products. Crystallization equipment is designed so that (1) the undesirable phenomena do not occur at all, and/or (2) the phenomena that do occur are carefully controlled. One key strategy is to exploit dual-impinging jets and multiphase flow to decouple nucleation and growth so that they can be individually controlled. Various configurations of micromixers were designed to provide controlled nucleation. Based on the dual-impinging-jet (DIJ) configuration, a physical explanation was provided for the discovery that a cooling micromixer can generate small crystals of uniform size and shape. An alternative design replaces the micromixing with the application of ultrasonication to decouple nucleation and flow rates. Based on these nucleation methods, a novel continuous crystallizer is designed where the slurry flow is combined with an air flow to induce a multiphase hydrodynamic instability that spontaneously generates slugs where the crystals continue to grow. These slugs are well-mixed without having the mixing blades in traditional crystallizer designs that induce undesirable uncontrolled crystallization phenomena. Another key strategy is to increase the degrees of freedom in the dynamic operation of the crystallizers. In the slug-flow continuous crystallizer, extra degrees of freedom for control of the crystal growth are created by spatially varying the temperature profile along the tube. In a semi-continuous crystallizer configuration, continuous seeding using a DIJ mixer is combined with growth rate control in a stirred tank to experimentally demonstrate the manufacture of uniform-sized crystals. In addition, temperature-cycling experiments are designed in batch crystallizers to substantially change crystal shape with only a small number of cycles. Experimental validation confirms that the proposed crystallizer designs reduce production time and equipment cost by orders of magnitude while suppressing secondary nucleation, attrition, and aggregation/agglomeration-dominant but undesired phenomena that worsen the ability to control the properties of crystals produced by most existing crystallizer designs.

Degree

thesis:*
Department dc:contributor.department
Massachusetts Institute of Technology. Department of Chemical Engineering.
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2015

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Jiang, Mo
Advisor dc:contributor.advisor
  • Richard D. Braatz.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/98708
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/98708

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Jiang, Mo. Pharmaceutical crystallization design using micromixers, multiphase flow, and controlled dynamic operations. Massachusetts Institute of Technology, 2015. http://hdl.handle.net/1721.1/98708